To maximize its cash runway while the Board conducts its review of strategic alternatives, Viracta has elected to close its ongoing pivotal Phase 2 clinical trial of Nana-val in relapsed/refractory ...
Ukraine's military intelligence says that North Korean troops are suffering heavy losses in the Kursk region and are facing ...
Kadokawa Corporation (9468 – Research Report), the Communication Services sector company, was revisited by a Wall Street analyst today. Analyst ...
The appointment comes as Boeing seeks to rehabilitate its reputation with customers, regulators and employees.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback